VWR (VWR) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
VWR Acquires Reliable Biopharmaceutical and BioArra
November 3, 2016 6:10 AM EDTRADNOR, Pa., Nov. 3, 2016 /PRNewswire/ --Â VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, announced today the acquisition of two companies, Reliable Biopharmaceutical and BioArra.
Reliable Biopharmaceutical, a manufacturer of high quality active pharmaceutical ingredients (APIs) and high purity ingredients (HPIs) such as cGMP excipients and advanced intermediates for the biopharmaceutical industry, enhances VWR's growing custom chemical and biochemical manufacturing portfolio. Reliable Biopharmaceutical offers... More
VWR Corporation Reports Third Quarter 2016 Financial Results
November 3, 2016 6:00 AM EDTRADNOR, Pa., Nov. 3, 2016 /PRNewswire/ -- VWR Corporation (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, today reported its financial results for the third quarter ended September 30, 2016.
Highlights:
3Q16 diluted EPS of $0.31 vs. $0.08 in 3Q15, 3Q16 Adjusted EPS of $0.44 vs. $0.38 in 3Q15. Third quarter net sales of $1.14 billion, up 3.7% year-over-year, and up 1.6% on an organic basis.... More